• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment - Recommendations from an Expert Group from Austria, Germany, and Switzerland.

作者信息

Matzdorff Axel, Alesci Sonja R, Gebhart Johanna, Holzhauer Susanne, Hütter-Krönke Marie Luise, Kühne Thomas, Meyer Oliver, Ostermann Helmut, Pabinger Ingrid, Rummel Mathias, Sachs Ulrich J, Stauch Thomas, Trautmann-Grill Karolin, Wörmann Bernhard

机构信息

Department of Medicine II, Asklepios Clinic Uckermark, Schwedt, Germany.

IMD Blood Coagulation Centre, Bad Homburg, Germany.

出版信息

Oncol Res Treat. 2023;46 Suppl 2:5-44. doi: 10.1159/000529662. Epub 2023 Feb 14.

DOI:10.1159/000529662
PMID:36787705
Abstract
摘要

相似文献

1
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment - Recommendations from an Expert Group from Austria, Germany, and Switzerland.免疫性血小板减少症专家报告：当前的诊断与治疗——来自奥地利、德国和瑞士的专家组建议
Oncol Res Treat. 2023;46 Suppl 2:5-44. doi: 10.1159/000529662. Epub 2023 Feb 14.
2
Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI.免疫性血小板减少症——当前的诊断与治疗：德国血液学和肿瘤学学会、奥地利血液学和肿瘤学学会、瑞士血液学和肿瘤学学会、德国儿科学会和德国血栓与止血学会联合工作组的建议
Oncol Res Treat. 2018;41 Suppl 5:1-30. doi: 10.1159/000492187. Epub 2018 Sep 19.
3
Immunthrombozytopenie - aktuelle Diagnostik und Therapie: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, ÖGHO, SGH, GPOH und DGTI.免疫性血小板减少症——当前的诊断与治疗：德国血液学与肿瘤学学会、奥地利血液学与肿瘤学学会、瑞士血液学与肿瘤学学会、德国儿科肿瘤学与血液学学会和德国血栓与止血学会共同工作组的建议
Oncol Res Treat. 2018;41 Suppl 2:5-36. doi: 10.1159/000486384. Epub 2018 Apr 3.
4
[Tempora mutantur -- updated recommendations for the treatment of immune thrombocytopenia].[时代变迁——免疫性血小板减少症治疗的更新建议]
Oncol Res Treat. 2014;37 Suppl 2:3-4. doi: 10.1159/000357928.
5
[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].[成人原发性免疫性血小板减少症：奥地利血液学和肿瘤学会（ÖGHO）诊断与治疗共识声明]
Wien Klin Wochenschr. 2012 Feb;124(3-4):111-23. doi: 10.1007/s00508-012-0123-3. Epub 2012 Mar 3.
6
[Immune thrombocytopenia -- onkopedic guidelines update: recommendations of a joint working group of the DGHO, ÖGHO, SGH + SSH and GPOH].[免疫性血小板减少症——骨科指南更新：德国血液学和肿瘤学学会、奥地利血液学和肿瘤学学会、瑞士血液学和肿瘤学学会+瑞士儿科学会以及德国儿科血液学和肿瘤学学会联合工作组的建议]
Oncol Res Treat. 2014;37 Suppl 2:6-25. doi: 10.1159/000356910.
7
[Chinese expert consensus on the diagnosis and treatment of thromboembolism in patients with immune thrombocytopenia (2023)].《免疫性血小板减少症患者血栓栓塞症诊断与治疗中国专家共识（2023年版）》
Zhonghua Xue Ye Xue Za Zhi. 2023 Jan 14;44(1):6-11. doi: 10.3760/cma.j.issn.0253-2727.2023.01.002.
8
[Protocol for the study and treatment of primary immune thrombocytopenia: PTI-2018].[原发性免疫性血小板减少症的研究与治疗方案：PTI-2018]
An Pediatr (Engl Ed). 2019 Aug;91(2):127.e1-127.e10. doi: 10.1016/j.anpedi.2019.04.014. Epub 2019 Jun 6.
9
Updated Recommendations for the Treatment of Immune Thrombocytopenia.免疫性血小板减少症治疗的更新建议。
Clin Adv Hematol Oncol. 2020 Aug;18(8):442-446.
10
Editorial 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Basel, Switzerland, September 2009.社论 第三届洲际合作性免疫性血小板减少症研究组（ICIS）专家会议，瑞士巴塞尔，2009年9月
Ann Hematol. 2010 Jul;89 Suppl 1:1-2. doi: 10.1007/s00277-010-0979-0. Epub 2010 May 7.

引用本文的文献

1
Impact of Primary Chronic Immune Thrombocytopenia and Thrombopoietin Receptor Agonists Treatment Instructions on Daily Living: Results of a Multinational Cross-Sectional Survey.原发性慢性免疫性血小板减少症及血小板生成素受体激动剂治疗指南对日常生活的影响：一项跨国横断面调查结果
Patient Prefer Adherence. 2025 Aug 13;19:2445-2458. doi: 10.2147/PPA.S505337. eCollection 2025.
2
Immune thrombocytopenia in adolescents and young adults.青少年和青年的免疫性血小板减少症
Front Med (Lausanne). 2025 Mar 26;12:1553936. doi: 10.3389/fmed.2025.1553936. eCollection 2025.
3
Heat exposure and pediatric immune thrombocytopenia in Japan from 2011 to 2022: a nationwide space-timestratified case-crossover study.
2011年至2022年日本的热暴露与儿童免疫性血小板减少症：一项全国性时空分层病例交叉研究
Haematologica. 2025 May 1;110(5):1217-1220. doi: 10.3324/haematol.2024.287176. Epub 2025 Jan 23.
4
Analysis of Risk Factors and the Establishment of a Predictive Model for Thrombosis in Patients with Immune Thrombocytopenia.免疫性血小板减少症患者血栓形成的危险因素分析及预测模型的建立
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296241301398. doi: 10.1177/10760296241301398.
5
Insights on treatment of adult ITP: algorithm for management and role of multimodal therapy.成人免疫性血小板减少症治疗的见解：管理算法及多模式治疗的作用
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):678-684. doi: 10.1182/hematology.2024000594.
6
Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta-analysis.福斯他替尼用于成年免疫性血小板减少症患者：一项系统评价和荟萃分析。
EJHaem. 2024 Jun 21;5(4):651-660. doi: 10.1002/jha2.939. eCollection 2024 Aug.
7
Identification of an Unmet Medical Need: Height of Depression, Hypersomnia, and Sleep Apnea Positively Correlate With the Level of Fatigue in Patients With Immune Thrombocytopenia.未满足医疗需求的识别：免疫性血小板减少症患者的抑郁程度、睡眠过多和睡眠呼吸暂停与疲劳水平呈正相关。
Cureus. 2023 Oct 13;15(10):e47003. doi: 10.7759/cureus.47003. eCollection 2023 Oct.